IMNN

Imunon, Inc. IMNN

IMNN
Imunon, Inc. IBIO
iBio, Inc. INTS
Intensity Therapeutics, Inc. DWTX
Dogwood Therapeutics, Inc. LYRA
Lyra Therapeutics, Inc. RNAZ
TransCode Therapeutics, Inc. BRTX
BioRestorative Therapies, Inc. AEON
AEON Biopharma, Inc. ACXP
Acurx Pharmaceuticals, Inc. THAR
Tharimmune, Inc.

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode IMNN IBIO INTS DWTX LYRA RNAZ BRTX AEON ACXP THAR
6M -62.85 % -13.32 % -85.11 % 62.20 % 63.48 % 48.80 % -7.51 % 175.00 % -7.40 % 187.27 %
YTD -69.52 % -64.90 % -84.17 % 141.04 % -30.37 % -78.53 % 7.38 % -97.22 % -57.56 % 54.15 %
1Y -68.00 % -70.19 % -91.61 % 36.57 % -37.39 % -96.62 % -7.51 % -98.61 % -82.61 % 26.40 %
3Y -79.62 % -98.19 % -95.35 % -31.25 % -96.83 % -100.00 % -51.22 % -99.83 % -87.75 % -98.72 %
5Y -96.56 % -99.92 % -95.35 % -98.55 % -98.86 % -100.00 % -97.58 % -99.83 % -95.48 % -99.76 %
10Y -99.92 % -99.98 % -95.35 % -98.55 % -99.19 % -100.00 % -99.99 % -99.83 % -95.48 % -99.76 %
From the beginning -100.00 % -99.98 % -95.35 % -98.55 % -99.19 % -100.00 % -100.00 % -99.83 % -95.48 % -99.76 %

Dividend